Rhinehart himself states my concerns with his project: “I am no biologist though,” he admits, “and can’t isolate the placebo effect in a sample size of one.”

Rhinehart himself states my concerns with his project: “I am no biologist though,” he admits, “and can’t isolate the placebo effect in a sample size of one.” Which is why I am glad to hear the following: Rhinehart plans to raise money on the Kickstarter platform – a popular method of crowd-sourcing investment for entrepreneurial schemes. Next will be a large-scale controlled trial that’s been greenlit by an ethics board. Soylent is an interesting product that has received a lot of hype. I look forward to seeing the results of a well designed large-scale trial.